1.4. Tumour conference simulation: Minimally invasive oncology


Prof. Christiane Bruns

Priv.-Doz. Dr. med. Dominik Modest

Prof. Dr. med. Jens Ricke

Priv.-Doz. Dr. med. Christoph Benckert

Dr. Kerstin Schütte

Maximum number of participants: 12

Duration: 1,5 days 




other dates on request

Course fee: on request


Course objective: Patients with hepatocellular carcinoma benefit significantly of multidisciplinary treatment strategies. Besides internistical-oncological skills both surgical and interventional radiological techniques for local or locoregional tumor therapy have to be offered to exhaust all current treatment options. Moreover, a profound hepatological expertise in the treatment of the common underlying liver disease is essential. This course conveys knowledge about the diagnosis and treatment of patients with or without liver cirrhosis and hepatocellular carcinoma that goes beyond traditional subject boundaries. In the practical part image-guided radiological interventions will be explored especially.

Major target group

Visceral surgeons, gastroenterologists, hepatologists, oncologists and interventional radiologists. The practical part is aimed primarily to interventional radiologists with significant experience (at least 1 year, interstitial and vascular).

This course can be adapted to individual needs of e.g. hospitals and practitioners.


Meeting venue: Berlin



Day 1 
Hepatocellular carcinoma

  • Welcome, introduction to interdisciplinarity in HCC treatment
  • HCC treatment according to current guidelines, overview
  • Surgery in BCLC stage 0 and A
  • RFA in BCLC stage 0 and A
  • Case discussions – RFA vs. resection
  • Therapy concepts beyond guidelines – evidence for SIRT
  • Therapy concepts beyond guidelines – surgery in BCLC stage B
  • Case discussions – BCLC stage B
  • Liver function: what is important regarding decision making 
  • Case discussions and tumour board simulation
  • Test

Day 2
Metastatic colorectal cancer

  • Introduction to systemic and personalised therapy of mCRC
  • Resection of CRC liver metastases
  • RFA of CRC liver metastases
  • Case discussions – RFA vs. resection
  • SIRT in liver only mCRC from the perspective of the medical oncologist
  • Case discussions and tumour board simulation

Neuroendocrine carcinoma 

  • Treatment of mNET according to current guidelines
  • Evidence of SIRT     
  • Case discussions and tumour board simulation

Interdisciplinary clinical management of SIRT patients

  • Preparation and indication, which clinical paramters are important? Monitoring after SIRT, Follow-up
  • Prevention, identification and management of complications
  • Test
PDF-Dokument [569.9 KB]

Valuation of our latest courses

  • 06.-07.04.2017 - Tumorkonferenzsimulation für minimal-invasive Onkologie - Note: 1,3
  • 16.-17.03.2017 - Tumorkonferenzsimulation für minimal-invasive Onkologie - Note: 1,3
  • 10.-11.11.2016 - Tumorkonferenzsimulation für minimal-invasive Onkologie - Note: 1,1
  • 17.-18.03.2016 - Tumorkonferenzsimulation für minimal-invasive Onkologie - Note: 1,1
  • 10.-11.03.2016 - Tumorkonferenzsimulation für minimal-invasive Onkologie - Note: 1,2
  • 12.-13.02.2015 - Tumorkonferenzsimulation für minimal-invasive Onkologie - Note: 1,5

Registration Conditions:

Registration is compulsory. Cancellations recieved up to two weeks prior to the event date will be charged with a processing fee of 25,- Euros. After this date or in case of non-attendance, we will calculate the entire conference fee. Registration as well as cancellation must be in writing.


Please contact Madeleine Beneke for all general or booking requests.
phone: +49 391 6715561
e-mail: info@dafmt.de
address: Leipziger Strasse 44, 39120 Magdeburg/Germany